FBDD 2014 - 8th Annual Fragment-Based Drug Discovery: From Discovery to Lessons Learned

Using fragment-based technologies for drug design has an established place in the toolkit of drug discovery. However, as the field is maturing, a new set of questions is emerging, such as how to select the most suitable projects, are there new screening developments, how about weak binding compounds ? how does one screen for those? What are the best technologies to combine ? and are there new applications one needs to know about? What are the pro’s and con’s of using FBDD?